The Moderna Innovation and Technology Centre (MITC) in Harwell is the flagship part of a 10-year, £1 billion investment in ...

A new UK start-up called Dalton Tx emerged from stealth with seed financing of £4 million ($5.4 million) and a mission to ...

Earlier this year, PTC Therapeutics and Novartis' experimental therapy for Huntington's, mRNA splicing modifier PTC518 ...

According to a head-to-head trial called DEVOTE, which underpins the application, the high-dose of nusinersen slowed ...

Iberdomide, which is being positioned as a successor to Revlimid, will continue in EXCALIBER-RRMM as the study progresses to ...

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with healthcare innovation ...

The Houston facility has been selected as one that will make orforglipron, Lilly's new oral GLP-1 agonist for weight-loss, ...

The UK’s National Cancer Plan rightly puts patients at the heart of its ambitions, with a focus on prevention, early diagnosis, and support for those living with and beyond cancer. In practice, this ...

As President Donald Trump started his state visit to the UK, GSK unveiled a massive $30 billion investment in manufacturing ...

The first patient has already been treated with bemdaneprocel, a one-shot treatment designed to replace the ...

Accurate labelling is equally important in blood transfusion services. Effectively tracking blood as it moves from donation ...

Panellists voted by 8 to 3 – with one abstention – to change the CDC recommendations to state that MMRV is not recommended ...